BBK07 immunodominant peptides as serodiagnostic markers of lyme disease

Clinical and Vaccine Immunology

Volumn 18, Issue 3, 2011, Pages 406-413

  Coleman, Adam S ^a,b   Rossmann, Evelyn ^c   Yang, Xiuli ^a,b   Song, Haichen ^d   Lamichhane, Chinta M ^d   Iyer, Radha ^e   Schwartz, Ira ^e   Pal, Utpal ^a,b  

^a UNIVERSITY OF MARYLAND   (United States)

^b VIRGINIA MARYLAND REGIONAL COLLEGE OF VETERINARY MEDICINE   (United States)

^c Genzyme Virotech GmbH   (Germany)

^d ZOETIS   (United States)

^e NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; EPITOPE; PROTEIN BBK07; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIUM DETECTION; BORRELIA BURGDORFERI; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DOG; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNE RESPONSE; IMMUNOASSAY; IMMUNOREACTIVITY; LYME DISEASE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BIOLOGICAL MARKERS; BORRELIA BURGDORFERI; CLINICAL LABORATORY TECHNIQUES; DOGS; HUMANS; IMMUNODOMINANT EPITOPES; LYME DISEASE; SENSITIVITY AND SPECIFICITY; SEROLOGIC TESTS;

EID: 79952543496     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00461-10     Document Type: Article

References (38)

1. Aguero-Rosenfeld, M. E., J. Nowakowski, D. F. McKenna, C. A. Carbonaro, and G. P. Wormser. 1993. Serodiagnosis in early Lyme disease. J. Clin. Microbiol. 31:3090-3095.
2. Aguero-Rosenfeld, M. E., G. Wang, I. Schwartz, and G. P. Wormser. 2005. Diagnosis of Lyme borreliosis. Clin. Microbiol. Rev. 18:484-509.
3. Anonymous. 1995. Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease. Morb. Mortal. Wkly. Rep. 44:590-591.
4. Bacon, R. M., et al. 2003. Serodiagnosis of Lyme disease by kinetic enzyme-linked immunosorbent assay using recombinant VlsE1 or peptide antigens of Borrelia burgdorferi compared with 2-tiered testing using whole-cell lysates. J. Infect. Dis. 187:1187-1199.
5. Bacon, R. M., K. J. Kugeler, and P. S. Mead. 2008. Surveillance for Lyme disease - United States, 1992-2006. MMWR Surveill. Summ. 57:1-9.
6. Barbour, A. G., et al. 2008. A genome-wide proteome array reveals a limited set of immunogens in natural infections of humans and white-footed mice with Borrelia burgdorferi. Infect. Immun. 76:3374-3389.
7. Brissette, C. A., et al. 2010. The borrelial fibronectin-binding protein RevA is an early antigen of human Lyme disease. Clin. Vaccine Immunol. 17:274-280.
8. Burbelo, P. D., et al. 2010. Rapid, simple, quantitative, and highly sensitive antibody detection for Lyme. Dis. Clin. Vaccine Immunol. 17:904-909.
9. Coleman, A. S., and U. Pal. 2009. BBK07, a dominant in vivo antigen of Borrelia burgdorferi, is a potential marker for serodiagnosis of Lyme disease. Clin. Vaccine Immunol. 16:1569-1575.
10. Cox, D. L., et al. 1996. Limited surface exposure of Borrelia burgdorferi outer surface lipoproteins. Proc. Natl. Acad. Sci. U. S. A. 93:7973-7978.
11. DeLong, E. R., D. M. DeLong, and D. L. Clarke-Pearson. 1988. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44:837-845.
12. Earnhart, C. G., E. L. Buckles, J. S. Dumler, and R. T. Marconi. 2005. Demonstration of OspC type diversity in invasive human Lyme disease isolates and identification of previously uncharacterized epitopes that define the specificity of the OspC murine antibody response. Infect. Immun. 73: 7869-7877.
13. Elias, A. F., et al. 2002. Clonal polymorphism of Borrelia burgdorferi strain B31 MI: implications for mutagenesis in an infectious strain background. Infect. Immun. 70:2139-2150.
14. Goettner, G., et al. 2005. Improvement of Lyme borreliosis serodiagnosis by a newly developed recombinant immunoglobulin G (IgG) and IgM line immunoblot assay and addition of VlsE and DbpA homologues. J. Clin. Microbiol. 43:3602-3609.
15. Gomara, M. J., and I. Haro. 2007. Synthetic peptides for the immunodiagnosis of human diseases. Curr. Med. Chem. 14:531-546.
16. Heikkila, T., et al. 2002. Recombinant BBK32 protein in serodiagnosis of early and late Lyme borreliosis. J. Clin. Microbiol. 40:1174-1180.
17. Hunfeld, K. P., and P. Kraiczy. 2009. When is the best time to order a Western blot and how should it be interpreted? Curr. Probl. Dermatol. 37:167-177.
18. Iyer, R., J. M. Hardham, G. P. Wormser, I. Schwartz, and S. J. Norris. 2000. Conservation and heterogeneity of vlsE among human and tick isolates of Borrelia burgdorferi. Infect. Immun. 68:1714-1718.
19. Kaiser, R., and S. Rauer. 1999. Advantage of recombinant borrelial proteins for serodiagnosis of neuroborreliosis. J. Med. Microbiol. 48:5-10.
20. Lawrenz, M. B., et al. 1999. Human antibody responses to VlsE antigenic variation protein of Borrelia burgdorferi. J. Clin. Microbiol. 37:3997-4004.
21. Ledue, T. B., M. F. Collins, and W. Y. Craig. 1996. New laboratory guidelines for serologic diagnosis of Lyme disease: evaluation of the two-test protocol. J. Clin. Microbiol. 34:2343-2350.
22. Liang, F. T., et al. 1999. Sensitive and specific serodiagnosis of Lyme disease by enzyme-linked immunosorbent assay with a peptide based on an immunodominant conserved region of Borrelia burgdorferi vlsE. J. Clin. Microbiol. 37:3990-3996.
23. Lindenmayer, J. M., D. Marshall, and A. B. Onderdonk. 1991. Dogs as sentinels for Lyme disease in Massachusetts. Am. J. Public Health 81:1448-1455.
24. Magnarelli, L. A., E. Fikrig, S. J. Padula, J. F. Anderson, and R. A. Flavell. 1996. Use of recombinant antigens of Borrelia burgdorferi in serologic tests for diagnosis of Lyme borreliosis. J. Clin. Microbiol. 34:237-240.
25. Mathiesen, M. J., et al. 1998. Peptide-based OspC enzyme-linked immunosorbent assay for serodiagnosis of Lyme borreliosis. J. Clin. Microbiol. 36:3474-3479.
26. Mueller, M., et al. 2006. Identification of Borrelia burgdorferi ribosomal protein L25 by the phage surface display method and evaluation of the protein's value for serodiagnosis. J. Clin. Microbiol. 44:3778-3780.
27. Padula, S. J., F. Dias, A. Sampieri, R. B. Craven, and R. W. Ryan. 1994. Use of recombinant OspC from Borrelia burgdorferi for serodiagnosis of early Lyme disease. J. Clin. Microbiol. 32:1733-1738.
28. Pal, U., et al. 2004. OspC facilitates Borrelia burgdorferi invasion of Ixodes scapularis salivary glands. J. Clin. Invest. 113:220-230.
29. Piesman, J., and L. Eisen. 2008. Prevention of tick-borne diseases. Annu. Rev. Entomol. 53:323-343.
30. Ramamoorthy, R., and M. T. Philipp. 1998. Differential expression of Borrelia burgdorferi proteins during growth in vitro. Infect. Immun. 66:5119-5124.
31. Rasiah, C., S. Rauer, G. S. Gassmann, and A. Vogt. 1994. Use of a hybrid protein consisting of the variable region of the Borrelia burgdorferi flagellin and part of the 83-kDa protein as antigen for serodiagnosis of Lyme disease. J. Clin. Microbiol. 32:1011-1017.
32. Rauer, S., N. Spohn, C. Rasiah, U. Neubert, and A. Vogt. 1998. Enzyme-linked immunosorbent assay using recombinant OspC and the internal 14-kDa flagellin fragment for serodiagnosis of early Lyme disease. J. Clin. Microbiol. 36:857-861.
33. Roessler, D., U. Hauser, and B. Wilske. 1997. Heterogeneity of BmpA (P39) among European isolates of Borrelia burgdorferi sensu lato and influence of interspecies variability on serodiagnosis. J. Clin. Microbiol. 35:2752-2758.
34. Schwan, T. G., W. Burgdorfer, and C. F. Garon. 1988. Changes in infectivity and plasmid profile of the Lyme disease spirochete, Borrelia burgdorferi, as a result of in vitro cultivation. Infect. Immun. 56:1831-1836.
35. Simpson, W. J., M. E. Schrumpf, and T. G. Schwan. 1990. Reactivity of human Lyme borreliosis sera with a 39-kilodalton antigen specific to Borrelia burgdorferi. J. Clin. Microbiol. 28:1329-1337.
36. Steere, A. C. 2006. Lyme borreliosis in 2005, 30 years after initial observations in Lyme Connecticut. Wien. Klin. Wochenschr. 118:625-633.
37. Wang, G., et al. 2002. Disease severity in a murine model of Lyme borreliosis is associated with the genotype of the infecting Borrelia burgdorferi sensu stricto strain. J. Infect. Dis. 186:782-791. (Pubitemid 35013430)
38. Wilske, B., V. Fingerle, and U. Schulte-Spechtel. 2007. Microbiological and serological diagnosis of Lyme borreliosis. FEMS Immunol. Med. Microbiol. 49:13-21.